Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 3Completed 3Withdrawn 1Terminated 1

Sponsor Class

OTHER 3

Study Type

Observational 3Interventional 3

Sponsor

Cancer Type

Genitourinary 1

Conditions

Smoking Cessation 2Urinary Bladder Neoplasms 1Smoking 1Postoperative Complications 1Neoplasms 1Cigarette Smoker 1Alcohol Drinking 1

Interventions

Cyclophosphamide 1488Cisplatin 1410Paclitaxel 1316Radiotherapy 1259Carboplatin 1247Gemcitabine 1214Docetaxel 1110Bevacizumab 1029Fluorouracil 894Doxorubicin 786Dexamethasone 746Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 673Etoposide 673Irinotecan 634Filgrastim 621Cytarabine 584Leucovorin 578Nivolumab 557Vincristine 510Prednisone 474Cetuximab 464Bortezomib 457Erlotinib Hydrochloride 456Trastuzumab 448Methotrexate 437Lenalidomide 426Pemetrexed 419

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Interventional × Smoking Devices × Clear all
NCT05941858 2026-04-02

Online Tai Chi Intervention to Promote Smoking Cessation Among Cancer Survivors

Ohio State University Comprehensive Cancer Center

Phase NA Completed
68 enrolled

Neoplasms, Smoking Cessation

NCT00948129 2023-01-20

Mobile Smoking Cessation Intervention in Enhancing Cancer Outreach in Low-Income Adult Smokers

M.D. Anderson Cancer Center

Phase NA Completed
626 enrolled

Cigarette Smoker

NCT02188446 2019-02-04

STOP-OP

Rigshospitalet, Denmark

Phase NA Completed
105 enrolled
Genitourinary

Alcohol Drinking, Urinary Bladder Neoplasms, Postoperative Complications, Smoking, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡